Relationship between a diagnosis of kidney failure and heart diseases in patients with hyperkalemia

Josep Darbà1, Meritxell Ascanio2, Ainoa Agüera2

  • 1Department of Economics, Universitat de Barcelona, Barcelona, Spain.

PubMed

Insights

Diagnoses of kidney failure and heart disease significantly increase hyperkalemia risk. This study highlights the need for close patient monitoring to prevent future complications.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Hyperkalemia is a critical electrolyte imbalance.
  • Kidney failure and heart disease are known risk factors for hyperkalemia.
  • The causal relationship and diagnostic impact require further empirical investigation.

Purpose of the Study:

  • To determine the association between kidney failure and heart disease diagnoses and the incidence of hyperkalemia.
  • To evaluate the causal impact of these diagnoses on hyperkalemia using a regression discontinuity design.
  • To provide empirical insights into the management of patients with co-existing conditions.

Main Methods:

  • Utilized a fuzzy regression discontinuity design (RDD).
  • Harnessed the potassium level threshold (6 mEq/L) as a diagnostic criterion for hyperkalemia.
  • Analyzed patient diagnosis data for kidney failure and heart disease.

Main Results:

  • A diagnosis of kidney failure or heart disease significantly increases the risk of developing hyperkalemia.
  • Kidney failure diagnosis probability increased by 11.2% around the 6 mEq/L potassium cut-off.
  • Hypertension and depression diagnoses were also associated with increased hyperkalemia likelihood (6.8% and 8.8% respectively).

Conclusions:

  • Kidney failure and heart disease have a significant causal impact on hyperkalemia development.
  • Monitoring patients with these conditions is crucial for preventing severe complications.
  • Findings were robust across various analytical specifications and placebo tests.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
523
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
461